Jason D. Fontenot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jason D. Fontenot has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alexander Y Rudensky
Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98195, USA
1 shared publicationAlexander Y. Rudensky
1 shared publicationAndrew G. Farr
1 shared publication- James Dooley
Translational Immunology Laboratory, VIB, Leuven, Belgium
1 shared publication - Jeffrey P. Rasmussen
University of Washington
1 shared publication Luke M. Williams
1 shared publication
Latest Publications
- Top Cited Papers
- 22 March 2005
- Published by Springer Nature in Nature Immunology
- Vol. 6 (4) , 331-337
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
The random generation of antigen receptors in developing lymphocytes results in a considerable risk of autoimmunity. Regulatory T cells (Treg cells) act in a dominant, trans-acting way to actively suppress immune activation and maintain immune tolerance. Here, we discuss the principal advances in our understanding of the molecular mechanisms of Treg cell development and function with particular emphasis on the forkhead transcription factor Foxp3. Accumulating evidence suggests that Treg cells represent a dedicated T cell lineage and that Foxp3 functions as the Treg cell lineage specification factor. The aggressive early-onset lymphoproliferative syndrome resulting from Foxp3 deficiency identifies Treg cells as vital mediators of immunological tolerance to self and Foxp3 as the mediator of the genetic mechanism of dominant tolerance.
- 22 March 2005
- Published by Springer Nature in Nature Immunology
- Vol. 6 (4) , 331-337
Top Cited PapersA well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
The random generation of antigen receptors in developing lymphocytes results in a considerable risk of autoimmunity. Regulatory T cells (Treg cells) act in a dominant, trans-acting way to actively suppress immune activation and maintain immune tolerance. Here, we discuss the principal advances in our understanding of the molecular mechanisms of Treg cell development and function with particular emphasis on the forkhead transcription factor Foxp3. Accumulating evidence suggests that Treg cells represent a dedicated T cell lineage and that Foxp3 functions as the Treg cell lineage specification factor. The aggressive early-onset lymphoproliferative syndrome resulting from Foxp3 deficiency identifies Treg cells as vital mediators of immunological tolerance to self and Foxp3 as the mediator of the genetic mechanism of dominant tolerance.
- 1 April 2004
- Published by Elsevier in Seminars in Immunology
- Vol. 16 (2) , 73-80
Molecular aspects of regulatory T cell development
- 1 April 2004
- Published by Elsevier in Seminars in Immunology
- Vol. 16 (2) , 73-80
Molecular aspects of regulatory T cell development